Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis

INTRODUCTION: Hyperprogressive disease (HPD) is a paradoxically rapid disease progression during or shortly after antitumor treatment, especially immune checkpoint inhibitors (ICIs). Various diagnosis criteria of HPD cause heterogeneous incidence rates in different clinical research, and there is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zijun, Bian, Jin, Zhang, Junwei, Zhang, Ting, Lu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381837/
https://www.ncbi.nlm.nih.gov/pubmed/35992878
http://dx.doi.org/10.3389/fonc.2022.843707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381837/
https://www.ncbi.nlm.nih.gov/pubmed/35992878
http://dx.doi.org/10.3389/fonc.2022.843707

Ejemplares similares